文献速递肾移植

肾移植后反复尿路感染对移植物及患者结局的影响

Effects of recurrent urinary tract infections on graft and patient outcomes after kidney transplantation.
PubMed 文献 · Nephrol Dial Transplant · 2017-01-01

该回顾性队列研究纳入1999至2014年Barnes-Jewish医院2469例成人肾移植受者,比较无UTI、非反复UTI和反复UTI(R-UTI)的结局。R-UTI与更差的移植物存活和患者存活相关,且多药耐药革兰阴性菌感染风险更高。

要点

  • R-UTI定义:任意6个月内≥2次或任意12个月内≥3次UTI。
  • R-UTI与更差移植物存活独立相关(校正后HR 2.01)。
  • R-UTI与更差患者存活相关(HR 1.87),且多药耐药风险增高。

核心结论

  • R-UTI与更差的移植物和患者结局相关,且多药耐药革兰阴性菌感染风险更高。

研究设计与样本

  • 回顾性队列研究(1999-2014年),纳入Barnes-Jewish医院2469例成人肾移植受者,排除术后30天内死亡者。

主要发现

  • 2469例中,1835例(74.3%)无UTI,465例(18.8%)为非反复UTI,169例(6.8%)为R-UTI。
  • R-UTI vs 非反复UTI:移植物存活HR 1.45(95%CI 1.23-1.83,P<0.001);vs 无UTI:HR 2.11(95%CI 2.02-3.80,P<0.001)。
  • Cox回归校正混杂因素后,R-UTI与移植物存活HR 2.01(95%CI 1.53-2.66,P<0.001)。
  • 无UTI与非反复UTI患者存活无差异(HR 1.21,95%CI 0.91-1.63,P=0.181);R-UTI vs 非反复UTI患者存活HR 1.87(95%CI 1.21-2.89,P=0.005)。
  • R-UTI更可能由多药耐药革兰阴性菌引起(风险比1.49,95%CI 1.31-1.70,P<0.001)。

关键数值与推荐

  • UTI定义:尿样本细菌菌落形成单位>10^5/mL。
  • R-UTI定义:任意6个月内≥2次UTI或任意12个月内≥3次UTI。

临床怎么用

  • 肾移植后应重视R-UTI的监测与防治,因其与移植物和患者存活恶化相关。
  • 对R-UTI患者需关注多药耐药革兰阴性菌感染风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Urinary tract infections (UTIs) are common following kidney transplantation (KT); however, the influence of recurrent post-KT UTI (R-UTI) is not well-characterized. METHODS: We compared graft outcomes, patient outcomes and multidrug-resistance rates between patients with no UTI, nonrecurrent UTI (NR-UTI) (urine sample containing >105 bacterial colony-forming units/mL) and R-UTI (≥2 UTIs in any 6-month period or ≥3 UTIs in any 12-month period) post-KT in a retrospective cohort study (1999-2014) at Barnes-Jewish Hospital (St Louis, MO). All adult KT recipients were included and those experiencing mortality within 30 days of KT were excluded. RESULTS: Of 2469 recipients included, 1835 (74.3%) had no UTI, 465 (18.8%) had NR-UTI and 169 (6.8%) had R-UTI. R-UTI was associated with poorer graft survival compared with NR-UTI [hazard ratio (HR) 1.45; 95% confidence interval (CI) 1.23-1.83; P < 0.001) and no UTI (HR 2.11; 95% CI 2.02-3.80; P < 0.001). This relationship persisted after adjusting for confounding factors in Cox regression (HR 2.01; 95% CI 1.53-2.66; P < 0.001). There was no difference in patient survival between no UTI and NR-UTI (HR 1.21; 95% CI 0.91-1.63; P = 0.181); however, R-UTI was associated with poorer patient survival compared with nonrecurrent cases (HR 1.87; 95% CI 1.21-2.89; P = 0.005). R-UTI were more likely to be caused by multidrug-resistant Gram-negative organisms (risk ratio 1.49; 95% CI 1.31-1.70; P < 0.001). CONCLUSIONS: R-UTIs were associated with poorer graft and patient outcomes, as well as increased multidrug-resistance compared with nonrecurrent cases.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Britt NS, Hagopian JC, Brennan DC, et al. Effects of recurrent urinary tract infections on graft and patient outcomes after kidney transplantation. Nephrol Dial Transplant. 2017. PMID: 28967964. doi:10.1093/ndt/gfx237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。